DiaSys Diagnostic Systems GmbH of Holzheim at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

DiaSys Diagnostic Systems GmbH

Alte Straße 9, 65558 Holzheim
Germany
Telephone +49 6432 9146-0
Fax +49 6432 9146-32
marketing@diasys.de

Contact

Dr. Guenther Gorka

CEO

Peter Zöller

CEO

Christophe Bayet

General Manager Global Business / Head of Sales; Responsible for: West-Europe, Scandinavia, Maghreb, French-Africa

Péter Aradi

Area Business Director; Responsible for: from East-Europe to East Africa; Kazakhstan and Uzbekistan

Chee Kian Teo

Area Business Director; Responsible for: South East Asia, Korea, Taiwan, Nepal, Australia, and Kyrgyzstan

Roland Heyer

Area Business Director; Responsible for: South and Middle America, Portugal, South African countries

Dr. Michael Sprinzl

Area Business Director; Responsible for: Czech Republic and Slovakia

Irene Delseith-Hermsdorf

Head of Marketing / Product Manager Reagents: Lipids & Atherosclerosis

Isabella Wieland

Product Manager Reagents: Diabetes, Electrolytes (except lactate), Liver, Iron Metabolism, Pancreatic Function

Andreas Bäcker

Product Manager Reagents: Cardiac Markers, Inflammatory & Rheumatoid Arthritis, Immune System, Nutrition, Renal Function

David Ehlers

Product Manager Systems: respons® system family, InnovaStar®, SQS, SensoStar

Dominik Bender

Product Manager Systems: BioMajesty® JCA-6010/C, StarDust MC15, Water purification

Carmen Pott

Supply Chain Management

Our range of products

Product categories

  • 02  Laboratory technology
  • 02.01  Analyser systems / equipment

Analyser systems / equipment

  • 03  Diagnostic tests
  • 03.01  Clinical chemistry
  • 03.01.05  Other equipment for clinical chemistry

Other equipment for clinical chemistry

  • 03  Diagnostic tests
  • 03.07  Other diagnostics

Other diagnostics

About us

Company details

Diagnostic Reagents and System Solutions of Outstanding Quality!

DiaSys Diagnostic Systems is a leading specialist in development and manufacturing of diagnostic system solutions. Our goal is to combine high quality with ease of use and to reduce the environmental burden. Focusing on clinical chemistry and immunoturbidimetric tests, DiaSys has introduced more than 100 reagents in user-friendly kits for manual or automated use. DiaSys reagents ensure reliable results in routine and special diagnostics as e.g. diabetes, metabolic syndrome, lipid disorders, iron metabolism, pancreatic, kidney or liver diseases.

The instrumentation portfolio comprises automated clinical chemistry analyzers for small to medium sized laboratories (respons®910, respons®920, respons®940 and BioMajesty®JCA-BM 6010/C), semi-automated analyzers (StarDust MC15) and POCT instruments (InnovaStar® and SensoStar). Additionally, DiaSys offers a broad range of calibrators (TruCal) and quality control material (TruLab).

DiaSys continuously expands its reagent and system portfolio.

At the beginning of 2020, DiaSys launched a new sensitive marker for severe and systemic bacterial infections – Procalcitonin FS. DiaSys Procalcitonin FS is a fluid-stable, particle enhanced immunoturbidimetric assay with good precision at clinical cut-offs for sepsis. The assay has an outstanding onboard and calibration stability. The performance of Procalcitonin FS is comparable to established methods, presenting a reliable alternative for clinical chemistry analyzers.

DiaSys is an ISO certified company since 1996 (ISO 13485). To date, customers and partners in more than 100 countries rely on DiaSys’ quality.

More Less

Company data

Foundation

1991

Area of business
  • Laboratory Equipment
  • Diagnostics